sold 3k of those day trade shares for a 70 cent per share profit first thing this morning it was a good trade.
actually a friend of mine tried to get me in at 12 but I didnt but he persisted and I got in at 80 and out at 600
it has already sold more than that this quarter. analysts are expecting 1.8B in Sovaldi sales this quarter ending at end of month.you can do your own math as the script numbers are available weekly.
wait til you have owned this longer than 3 weeks try 1 yr then get impatient. personally unless it just keeps going up I dont want it to go up too much til I have owned it for a year or more. I added another 3400 shares today looking to make a trading profit to bring down the cost on the other 24k shares I own. This is over 1/2 of my portfolio, I have nt been sold on anything as much as this since I bought AAPL at 80. dont let them talk you out of your shares finny.
not trying to add salt to any wounds but if it rallies to 11.05 then I will feel that I missed the boat and it should go on up. I think it trades sideways to down from here til june. but it is just an opinion and there are lots of them. But $10.40 is trying to guess a low entry point it is the point at where I WILL buy and private miltz the NAV has not been steadily increasing.look up the nav for the last 6 quarters
I sold 20% at 159 and bought some more GILD at 79.40 will look at Jazz to add to my core again if it goes below 154 but still holding the largest part of my core of 6500 shares
according to what I remember IPCI presenting the only way to abuse their drug was to overdose.
you have to read between the lines on the spin from various companies they give you what they want and leave out the fine detail, They make it sound the same but it isnt, The two things today are directly in response to that detail. Same as Zohdro but different, drug resistant but not in all ways. It is called PR for your best foot forward. is it accurate, yes but not fully disclosing.
look at the post above by tswenor, purdue only listed 2 ways whereas there are many other ways, drug abusers are very smart when it comes to getting their highs, as has been posted IPCI feels their drug abuse resistance is better and if that is so then they will be number uno.
dont be, it does the same type of results for pain relief but IT IS ANTI TAMPERING. rexista would do the same as oxycontin but be anti tampering. they are not opposites. My feeling is that if this is the reason IPCI sold off today then it is time to buy as it does not reduce the income prospects. The real question is why didnt Purdue introduce this before their patent expired, my guess is that profits outbid the need to get a anti drug tampering fix. shame on purdue.
i realize that but earnings are key with me, ANDAs are not that hard to decide to do imo NDA are more difficult, the only deal right now with ANDA is the roadblock at the FDA which once you get one is like having a patent.
IG future earnings are only 1/3 or less per share of IPCI so they are not really comparable, I like IPCI right now a lot better.
sure would like to see someone take that order out then it could go up, big orders act as floors or ceilings, I just believe it is a tactic and not really someone trying to sell